Psychedelics Regs May Not Shift Under Trump, Despite RFK Jr. Rhetoric

By Luke Zarzecki / January 16, 2025 at 10:55 AM

As a new association prepares to advocate on Capitol Hill for medical use of psychedelics, experts say regulations on the drugs will likely remain the same under President-elect Donald Trump, and in contrast to comments made by Trump’s pick to lead HHS, Robert F. Kennedy Jr., the biggest barrier to the treatments is the U.S. Drug Enforcement Administration (DEA) not FDA.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.